пятница, 26 августа 2016 г.

JMP Securities Raises Vanda Pharmaceuticals Inc. (VNDA) Price Target to $22.00

JMP Securities Raises Vanda Pharmaceuticals Inc. (VNDA) Price Target to $22.00


The brokerage currently has a "market outperform" rating on the biopharmaceutical company's stock. JMP Securities' price objective indicates a potential upside of 55.26% from the company's current price.



from Biotech News